Bone Biologics Statistics
NASDAQ: BBLGHealthcareBiotechnologyUSD
0.4691-0.0184 (-3.77%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Bone Biologics by the numbers
Bone Biologics has a market capitalization of $1.3 million based on 2.76M shares outstanding. With trailing EPS of $-1.37, Bone Biologics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.1% below its 50-day average and 59.5% below its 200-day average.
Average daily trading volume is 378.20K shares, or about $177,415 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BBLG valuation vs. peer median
| Metric | BBLG | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.29M | $1.75M | -26% |
| Avg. volume | 378.20K | 1.81M | -79% |
Peer median across 8 companies: BDRX, DCOY, SCNI, CRIS, EDVA, ARTL, LABT, VBIO.
Valuation
- Market cap
- $1.29M
- EPS (TTM)
- $-1.37
- Shares outstanding
- 2.76M
Price and trading
- Previous close
- 0.4875
- Open
- 0.475
- Day range
- 0.468 – 0.475
- 52-week range
- 0.428 – 2.76
- 50-day moving average
- 0.6177
- Beta
- —
- Volume
- 9.63K
- Average volume
- 378.20K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 1.29M
- Forward Pe
- -0.70
- Eps
- -1.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.76
- Week52 Low
- 0.43
- Avg Volume
- 378.20K
- Shares Outstanding
- 2.76M
- Ma50
- 0.62
- Ma200
- 1.16
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -83.00%
- Pct From52w Low
- 9.60%